| Pyrimidine, 4-[1,1'-biphenyl]-4-yl-6-(3,5-dibromophenyl)-2-phenyl- |
PYRIMIDINE, 4-[1,1'-BIPHENYL]-4-YL-6-(3,5-DIBROMOPHE NYL)- 2-PHENYL- |
1393350-29-2 |
| RY796 |
2-(DIMETHYLAMINO)-5-[(2-METHYL-1-OXOPROPYL)AMINO]-N-[(1R)-1-PHENYLETHYL]-BENZAMIDE |
1393441-53-6 |
| JD-5037 |
JD-5037 |
1392116-14-1 |
| (S)-3,10-dibromo-6-phenyl-6H-benzo[5,6][1,3]oxazino[3,4-a]indole |
(S)-3,10-二溴-6-苯基-6H-苯并[5,6] [1,3]恶嗪并[3,4-Α]吲哚 |
1392102-38-3 |
| PF-05241328 |
1-[5-CHLORO-6-(2-METHYLPROPOXY)PYRIDIN-3-YL]-3-METHYL-N-METHYLSULFONYLINDAZOLE-5-CARBOXAMIDE |
1387633-03-5 |
| M2698 |
M2698 |
1379545-95-5 |
| 2-Chloro-3,5-dinitropyridin-4-amine |
2-Chloro-3,5-dinitropyridin-4-amine |
1378875-15-0 |
| Naldemedine |
NALDEMEDINE |
1374774-70-5 |
| Naldemedine intermediate |
Naldemedine intermediate |
1374774-68-1 |
| CO-1686 intermediate 1 |
CO-1686中间体1 |
1374507-25-1 |
| MK-8031 |
UBROGEPANT |
1374248-81-3 |
| Ubrogepant |
乌布吉泮 |
1374248-77-7 |
| 2,9-Diazaspiro[5.5]undecan-1-one, 2-(1H-indol-3-ylMethyl)-9-(4-Methoxy-2-pyriMidinyl)- |
2,9-Diazaspiro[5.5]undecan-1-one, 2-(1H-indol-3-ylMethyl)-9-(4-Methoxy-2-pyriMidinyl)- |
1373765-19-5 |
| Lee011 intermediate |
帕布昔利布中间体 |
1374639-76-5 |
| 2-bromo-1,3-dimethyl-5-(3-(methylsulfonyl)propoxy)benzene |
1372195-69-1 |
1372195-69-1 |
| BZ-PHE-BOROLEU |
1-(5-CYCLOHEXYL-2-OXO-1-PROPYL-3H-1,4-BENZODIAZEPIN-3-YL)-3-[4-(4-PYRIDIN-3-YLPIPERAZIN-1-YL)PHENYL]UREA |
1370037-52-7 |
| NMP-7 |
(9-PENTYLCARBAZOL-3-YL)-PIPERIDIN-1-YLMETHANONE |
1358039-07-2 |
| N-Me-aminopyrimidinone 9 |
N-Me-aminopyrimidinone 9 |
1356834-62-2 |
| ALK/IGF1R inhibitor |
AZD3463 |
1356962-20-3 |
| Naloxegol Oxalate |
聚乙二醇纳诺醇 |
1354744-91-4 |
